Cheol Keun Chung

Title: The Innovative Contributions of Cheol Keun Chung

Introduction

Cheol Keun Chung is a notable inventor based in Westfield, NJ (US), recognized for his significant contributions to the field of chemistry. He holds a total of seven patents, showcasing his innovative spirit and dedication to advancing scientific knowledge. His work primarily focuses on the development of novel processes that have potential applications in cancer treatment.

Latest Patents

One of Cheol Keun Chung's latest patents is titled "Regioselective N-2 arylation of indazoles." This patent describes a novel process for the efficient preparation of an asymmetric compound, which includes a copper-catalyzed, carbon-nitrogen cross-coupling step. The process can be utilized to manufacture poly (ADP-ribose) polymerase (PARP) inhibitors, which are promising for cancer treatment. Specifically, the invention outlines a method for producing the PARP inhibitor, 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide.

Career Highlights

Throughout his career, Cheol Keun Chung has worked with prominent organizations, including Merck Sharp & Dohme Corporation and the California Institute of Technology. His experience in these esteemed institutions has allowed him to refine his skills and contribute to groundbreaking research in the field of medicinal chemistry.

Collaborations

Cheol Keun Chung has collaborated with notable colleagues, including Guy R Humphrey and John Limanto. These partnerships have fostered an environment of innovation and have led to the successful development of various projects and patents.

Conclusion

Cheol Keun Chung's work exemplifies the spirit of innovation in the field of chemistry. His contributions, particularly in the development of processes for cancer treatment, highlight the importance of research and collaboration in advancing medical science. His seven patents reflect a commitment to improving healthcare through innovative solutions.